RaySearch Laboratories AB (publ) announces that Royal Brisbane and Women's Hospital (RBWH) has entered a new era of cancer treatment by replacing its former photon planning system with treatment planning system RayStation®*. The adaptive workflow functionality and multi-criteria optimization capabilities of RayStation will help sustain RBWHs position as one of the region’s most-advanced treatment centers.
RBWH is the largest medical facility in Queensland, Australia, employing more than 8,000 multidisciplinary staff across a range of clinical areas. The hospital is known for its preeminent cancer treatment using a broad spectrum of advanced treatment types.
Chosen for its adaptive workflow functionality and multi-criteria optimization, RayStation will provide RBWH oncology specialists with innovative tools to treat different cancer types in the most-efficient and precise way possible with its Varian** treatment machines.
Representatives of alphaXRT, the official RaySearch distributor in the region, which is responsible for the deal, consider RayStation the most-advanced solution available and has the tools to equip RBWH to deliver the very best in innovative cancer treatment.
Johan Löf, founder and CEO, RaySearch, says: “Cancer treatment is evolving quickly, and we are pleased to support Royal Brisbane and Women's Hospital staff in Queensland with a treatment planning system uniquely designed with adaptive workflows and multi-criteria optimization to meet the needs of busy hospitals.”
The order was received and mainly generated revenues within Q4 2019.
About Royal Brisbane and Women's Hospital
Firmly established as a world-leading healthcare, research and innovation hub, Royal Brisbane and Women's Hospital in Australia has close to a thousand beds. It provides more than one tenth of all patient services in Queensland as well as services to patients in Northern New South Wales and the Northern Territory. More information about Royal Brisbane and Women's Hospital is available here.
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare®*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with next-generation oncology information system RayCare. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
** The mark VARIAN is trademark of Varian Medical Systems, Inc. There is no association, sponsorship and/or endorsement between RaySearch or related entities with Varian Medical Systems.
For further information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59